PH
Insider
Peter Heerma
EVP, CHIEF COMMERCIAL OFFICERPeter Heerma (EVP, CHIEF COMMERCIAL OFFICER) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $17.7M of TVTX (280,358 sh across 5 lots, as filed), executed Sep 15.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$18.7M
shares × price, as filed
Last traded
Sep 17
Filed Sep 17
Median ADV $123.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $18.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
6 filings
Sector per market data · by filing · past 12 months
Most traded names
TVTXRecent filings
TVTXSALE
Travere Therapeutics, Inc.
View filing →
$17.7M280,358 sh across 5 lots
Exec Sep 15
Filed Sep 17 · 9:35 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $101K
2,174 sh × $46.65
Exec May 5
Filed May 6 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $303K
7,215 sh × $41.93
Exec Apr 14
Filed Apr 15 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $235K
7,310 sh × $32.12
Exec Feb 3
Filed Feb 3 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $199K
4,980 sh × $40.00
Exec Dec 24 2025
Filed Dec 29 2025 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $196K
5,591 sh × $35.00
Exec Oct 31 2025
Filed Nov 4 2025 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $104K
5,166 sh × $20.12
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET